Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

The androgen receptor in the hypothalamus positively regulates hind-limb muscle mass and voluntary physical activity in adult male mice.

Clarke MV, Russell PK, Zajac JD, Davey RA.

J Steroid Biochem Mol Biol. 2019 May;189:187-194. doi: 10.1016/j.jsbmb.2019.02.018. Epub 2019 Mar 8.

PMID:
30853652
2.

NS1, Dengue's Dagger.

Halstead SB, Russell PK, Brandt WE.

J Infect Dis. 2019 Feb 19. pii: jiz083. doi: 10.1093/infdis/jiz083. [Epub ahead of print] No abstract available.

PMID:
30783665
3.

The androgen receptor in bone marrow progenitor cells negatively regulates fat mass.

Russell PK, Mangiafico S, Fam BC, Clarke MV, Marin ES, Andrikopoulos S, Wiren KM, Zajac JD, Davey RA.

J Endocrinol. 2018 Apr;237(1):15-27. doi: 10.1530/JOE-17-0656. Epub 2018 Jan 31.

PMID:
29386237
4.

Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone loss.

Starczak Y, Reinke DC, Barratt KR, Ryan JW, Russell PK, Clarke MV, St-Arnaud R, Morris HA, Davey RA, Atkins GJ, Anderson PH.

J Steroid Biochem Mol Biol. 2018 Mar;177:77-82. doi: 10.1016/j.jsbmb.2017.10.022. Epub 2017 Oct 28.

PMID:
29107736
5.

Androgen Action via the Androgen Receptor in Neurons Within the Brain Positively Regulates Muscle Mass in Male Mice.

Davey RA, Clarke MV, Russell PK, Rana K, Seto J, Roeszler KN, How JMY, Chia LY, North K, Zajac JD.

Endocrinology. 2017 Oct 1;158(10):3684-3695. doi: 10.1210/en.2017-00470.

PMID:
28977603
6.

Challenges to the Design of Clinical Trials for Live-Attenuated Tetravalent Dengue Vaccines.

Russell PK, Halstead SB.

PLoS Negl Trop Dis. 2016 Aug 11;10(8):e0004854. doi: 10.1371/journal.pntd.0004854. eCollection 2016 Aug. No abstract available.

7.

Response to Hadinegoro et al.

Halstead SB, Russell PK.

Vaccine. 2016 Aug 5;34(36):4275. doi: 10.1016/j.vaccine.2016.06.013. No abstract available.

PMID:
27452652
8.

Muscle-specific androgen receptor deletion shows limited actions in myoblasts but not in myofibers in different muscles in vivo.

Rana K, Chiu MW, Russell PK, Skinner JP, Lee NK, Fam BC, Zajac JD, MacLean HE.

J Mol Endocrinol. 2016 Aug;57(2):125-38. doi: 10.1530/JME-15-0320. Epub 2016 Jul 8.

PMID:
27402875
9.

The Zika Pandemic - A Perfect Storm?

Russell PK.

PLoS Negl Trop Dis. 2016 Mar 18;10(3):e0004589. doi: 10.1371/journal.pntd.0004589. eCollection 2016 Mar. No abstract available.

10.

Protective and immunological behavior of chimeric yellow fever dengue vaccine.

Halstead SB, Russell PK.

Vaccine. 2016 Mar 29;34(14):1643-7. doi: 10.1016/j.vaccine.2016.02.004. Epub 2016 Feb 10. Review.

PMID:
26873054
11.

Correction for Osterholm et al., Transmission of Ebola Viruses: What We Know and What We Do Not Know.

Osterholm MT, Moore KA, Kelley NS, Brosseau LM, Wong G, Murphy FA, Peters CJ, LeDuc JW, Russell PK, Van Herp M, Kapetshi J, Muyembe JJ, Ilunga BK, Strong JE, Grolla A, Wolz A, Kargbo B, Kargbo DK, Sanders DA, Kobinger GP.

MBio. 2015 Jul 21;6(4):e01154. doi: 10.1128/mBio.01154-15. No abstract available.

12.

A Role for the Calcitonin Receptor to Limit Bone Loss During Lactation in Female Mice by Inhibiting Osteocytic Osteolysis.

Clarke MV, Russell PK, Findlay DM, Sastra S, Anderson PH, Skinner JP, Atkins GJ, Zajac JD, Davey RA.

Endocrinology. 2015 Sep;156(9):3203-14. doi: 10.1210/en.2015-1345. Epub 2015 Jul 2.

PMID:
26135836
13.

Transmission of Ebola viruses: what we know and what we do not know.

Osterholm MT, Moore KA, Kelley NS, Brosseau LM, Wong G, Murphy FA, Peters CJ, LeDuc JW, Russell PK, Van Herp M, Kapetshi J, Muyembe JJ, Ilunga BK, Strong JE, Grolla A, Wolz A, Kargbo B, Kargbo DK, Sanders DA, Kobinger GP.

MBio. 2015 Feb 19;6(2):e00137. doi: 10.1128/mBio.00137-15. Review. Erratum in: MBio. 2015;6(4):e01154. Formenty, Pierre [Deleted].

14.

Androgen receptor action in osteoblasts in male mice is dependent on their stage of maturation.

Russell PK, Clarke MV, Cheong K, Anderson PH, Morris HA, Wiren KM, Zajac JD, Davey RA.

J Bone Miner Res. 2015 May;30(5):809-23. doi: 10.1002/jbmr.2413.

15.

The Human Hookworm Vaccine.

Hotez PJ, Diemert D, Bacon KM, Beaumier C, Bethony JM, Bottazzi ME, Brooker S, Couto AR, Freire Mda S, Homma A, Lee BY, Loukas A, Loblack M, Morel CM, Oliveira RC, Russell PK.

Vaccine. 2013 Apr 18;31 Suppl 2:B227-32. doi: 10.1016/j.vaccine.2012.11.034. Review.

16.

Identification of gene pathways altered by deletion of the androgen receptor specifically in mineralizing osteoblasts and osteocytes in mice.

Russell PK, Clarke MV, Skinner JP, Pang TP, Zajac JD, Davey RA.

J Mol Endocrinol. 2012 May 29;49(1):1-10. doi: 10.1530/JME-12-0014. Print 2012 Aug.

PMID:
22525354
17.

U.S. medical countermeasure development since 2001: a long way yet to go.

Russell PK, Gronvall GK.

Biosecur Bioterror. 2012 Mar;10(1):66-76. doi: 10.1089/bsp.2012.0305. Review.

PMID:
22455680
18.

Project BioShield: what it is, why it is needed, and its accomplishments so far.

Russell PK.

Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S68-72.

PMID:
17582574
19.

Swine influenza a outbreak, Fort Dix, New Jersey, 1976.

Gaydos JC, Top FH Jr, Hodder RA, Russell PK.

Emerg Infect Dis. 2006 Jan;12(1):23-8.

20.

History of U.S. military contributions to the study of vaccines against infectious diseases.

Artenstein AW, Opal JM, Opal SM, Tramont EC, Peter G, Russell PK.

Mil Med. 2005 Apr;170(4 Suppl):3-11.

PMID:
15916278
22.

Effect of vaccination with a recombinant fusion protein encoding an astacinlike metalloprotease (MTP-1) secreted by host-stimulated Ancylostoma caninum third-stage infective larvae.

Hotez PJ, Ashcom J, Zhan B, Bethony J, Loukas A, Hawdon J, Wang Y, Jin Q, Jones KC, Dobardzic A, Dobardzic R, Bolden J, Essiet I, Brandt W, Russell PK, Zook BC, Howard B, Chacon M.

J Parasitol. 2003 Aug;89(4):853-5.

PMID:
14533704
23.

Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative.

Hotez PJ, Zhan B, Bethony JM, Loukas A, Williamson A, Goud GN, Hawdon JM, Dobardzic A, Dobardzic R, Ghosh K, Bottazzi ME, Mendez S, Zook B, Wang Y, Liu S, Essiet-Gibson I, Chung-Debose S, Xiao S, Knox D, Meagher M, Inan M, Correa-Oliveira R, Vilk P, Shepherd HR, Brandt W, Russell PK.

Int J Parasitol. 2003 Sep 30;33(11):1245-58. Review.

PMID:
13678639
24.

Effect of vaccinations with recombinant fusion proteins on Ancylostoma caninum habitat selection in the canine intestine.

Hotez PJ, Ashcom J, Bin Z, Bethony J, Williamson A, Hawdon JM, Jianjun F, Dobardzic A, Rizo I, Bolden J, Jin Q, Yan W, Dobardzic R, Chung-Debose S, Crowell M, Datu B, Delaney A, Dragonovski D, Jiang Y, Yueyuan L, Ghosh K, Loukas A, Brandt W, Russell PK, Zook BC.

J Parasitol. 2002 Aug;88(4):684-90.

PMID:
12197114
25.

Anthrax as a biological weapon, 2002: updated recommendations for management.

Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Gerberding J, Hauer J, Hughes J, McDade J, Osterholm MT, Parker G, Perl TM, Russell PK, Tonat K; Working Group on Civilian Biodefense.

JAMA. 2002 May 1;287(17):2236-52. Review. Erratum in: JAMA 2002 Oct 16;288(15):1849.

PMID:
11980524
26.

Tularemia as a biological weapon: medical and public health management.

Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, Lillibridge SR, McDade JE, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Tonat K; Working Group on Civilian Biodefense.

JAMA. 2001 Jun 6;285(21):2763-73. Review.

PMID:
11386933
27.

Economic obstacles to the optimal utilization of an AIDS vaccine.

Russell PK.

J Int Assoc Physicians AIDS Care. 1997 Sep;3(9):31-3.

PMID:
11364712
28.

The propeptide of the transforming growth factor-beta superfamily member, macrophage inhibitory cytokine-1 (MIC-1), is a multifunctional domain that can facilitate protein folding and secretion.

Fairlie WD, Zhang HP, Wu WM, Pankhurst SL, Bauskin AR, Russell PK, Brown PK, Breit SN.

J Biol Chem. 2001 May 18;276(20):16911-8. Epub 2001 Feb 26.

29.

Botulinum toxin as a biological weapon: medical and public health management.

Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K; Working Group on Civilian Biodefense.

JAMA. 2001 Feb 28;285(8):1059-70. Review. Erratum in: JAMA 2001 Apr 25;285(16):2081.

PMID:
11209178
30.

Epitope mapping of the transforming growth factor-beta superfamily protein, macrophage inhibitory cytokine-1 (MIC-1): identification of at least five distinct epitope specificities.

Fairlie WD, Russell PK, Wu WM, Moore AG, Zhang HP, Brown PK, Bauskin AR, Breit SN.

Biochemistry. 2001 Jan 9;40(1):65-73.

PMID:
11141057
31.

The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women.

Moore AG, Brown DA, Fairlie WD, Bauskin AR, Brown PK, Munier ML, Russell PK, Salamonsen LA, Wallace EM, Breit SN.

J Clin Endocrinol Metab. 2000 Dec;85(12):4781-8.

PMID:
11134143
32.

Expression of a TGF-beta superfamily protein, macrophage inhibitory cytokine-1, in the yeast Pichia pastoris.

Fairlie WD, Zhang H, Brown PK, Russell PK, Bauskin AR, Breit SN.

Gene. 2000 Aug 22;254(1-2):67-76.

PMID:
10974537
33.

The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1.

Bauskin AR, Zhang HP, Fairlie WD, He XY, Russell PK, Moore AG, Brown DA, Stanley KK, Breit SN.

EMBO J. 2000 May 15;19(10):2212-20.

34.

Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Koerner JF, Layton M, McDade J, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Schoch-Spana M, Tonat K.

JAMA. 2000 May 3;283(17):2281-90. Review.

PMID:
10807389
35.

Vaccines in civilian defense against bioterrorism.

Russell PK.

Emerg Infect Dis. 1999 Jul-Aug;5(4):531-3. No abstract available.

36.

Screening procedure for Pichia pastoris clones containing multiple copy gene inserts.

Fairlie WD, Russell PK, Zhang HP, Breit SN.

Biotechniques. 1999 Jun;26(6):1042-4. No abstract available.

37.

Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, Hauer J, Layton M, McDade J, Osterholm MT, O'Toole T, Parker G, Perl T, Russell PK, Tonat K.

JAMA. 1999 Jun 9;281(22):2127-37. Review.

PMID:
10367824
38.

Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Hauer J, McDade J, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Tonat K.

JAMA. 1999 May 12;281(18):1735-45. Review. Erratum in: JAMA 2000 Apr 19;283(15):1963.

PMID:
10328075
39.

MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation.

Fairlie WD, Moore AG, Bauskin AR, Russell PK, Zhang HP, Breit SN.

J Leukoc Biol. 1999 Jan;65(1):2-5. Review.

PMID:
9886240
40.

Biologic terrorism--responding to the threat.

Russell PK.

Emerg Infect Dis. 1997 Apr-Jun;3(2):203-4. No abstract available.

41.

Development of vaccines to meet public health needs: incentives and obstacles.

Russell PK.

Risk. 1996 Summer;7(3):239-52. No abstract available.

PMID:
11655077
42.

Potential of polymer microencapsulation technology for vaccine innovation.

Morris W, Steinhoff MC, Russell PK.

Vaccine. 1994 Jan;12(1):5-11. Review.

PMID:
8303941
43.

A new technologic synthesis. The Children's Vaccine Initiative.

Ramachandran S, Russell PK.

Int J Technol Assess Health Care. 1994 Winter;10(1):193-6. No abstract available.

PMID:
8157452
44.

The children's vaccine initiative. Technologic opportunities and management challenges.

Russell PK.

Ann N Y Acad Sci. 1993 Dec 21;700:1-6. No abstract available.

PMID:
8109859
45.

Military immunizations. Past, present, and future prospects.

Takafuji ET, Russell PK.

Infect Dis Clin North Am. 1990 Mar;4(1):143-58. Review.

PMID:
2407777
46.

Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteers.

McKee KT Jr, Bancroft WH, Eckels KH, Redfield RR, Summers PL, Russell PK.

Am J Trop Med Hyg. 1987 Mar;36(2):435-42.

PMID:
3826504
47.

Flaviviridae.

Westaway EG, Brinton MA, Gaidamovich SYa, Horzinek MC, Igarashi A, Kääriäinen L, Lvov DK, Porterfield JS, Russell PK, Trent DW.

Intervirology. 1985;24(4):183-92. Review.

PMID:
3000978
48.

Togaviridae.

Westaway EG, Brinton MA, Gaidamovich SYa, Horzinek MC, Igarashi A, Kääriäinen L, Lvov DK, Porterfield JS, Russell PK, Trent DW.

Intervirology. 1985;24(3):125-39. Review.

PMID:
2999027
49.

Human hypersensitivity to a sham vaccine prepared from mosquito-cell culture fluids.

Scott RM, Shelton AL, Eckels KH, Bancroft WH, Summers RJ, Russell PK.

J Allergy Clin Immunol. 1984 Dec;74(6):808-11.

PMID:
6150050
50.

Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cells.

Eckels KH, Scott RM, Bancroft WH, Brown J, Dubois DR, Summers PL, Russell PK, Halstead SB.

Am J Trop Med Hyg. 1984 Jul;33(4):684-9.

PMID:
6476216

Supplemental Content

Loading ...
Support Center